Global Deoxynucleotide Triphosphates (dNTPs) Market Size, Share and Industry Analysis by Regions, Countries, Types, and Applications, Forecast to 2028

SKU ID : Maia- 23915153

Publishing Date : 02-Jun-2023

No. of pages : 106

PRICE
3480
5220
6960

  • The global Deoxynucleotide Triphosphates (dNTPs) market size was valued at USD 280.01 Million in 2022 and will reach USD 489.9 Million in 2028, with a CAGR of 9.77% during 2022-2028.

    Deoxynucleotide triphosphates (dNTPs) are nucleoside triphosphates containing deoxyribose. They are the building blocks of DNA, and they will lose two phosphate groups when incorporating deoxyribonucleic acid in the replication process. Members of DNA transporters include dNTPs include deoxyadenosine triphosphate (dATP), deoxythymidine triphosphate (dTTP), deoxycytidine triphosphate (dCTP), deoxyguanosine triphosphate (dGTP) and deoxyuridine triphosphate (dUTP). Deoxynucleotide triphosphates (dNTPs) are widely used in pharmacy and research.

    Covid-19's nose swab PCR test is the most accurate and reliable test for diagnosing Covid-19. Covid-19's PCR test is a test used to diagnose people who are currently infected with novel coronavirus virus, which is the coronavirus causing Covid-19. Deoxynucleotide triphosphate (dNTP) is the basic component of nucleic acid molecule, so it is an essential component of PCR mixture, because new (amplified) DNA cannot be produced without them. Under the influence of COVID-19 epidemic, the number of patients in the world is increasing. As of June 30, 2021, the number of confirmed cases in COVID-19 has reached 182,580,354 and the death toll is 3,953,846. In order to diagnose whether Covid-19 is infected or not, PCR test has become a necessary means of detection, which is helpful for the government to control the disease. The demand for PCR test is growing rapidly, so the demand for Deoxynucleotide Triphosphates (dNTPs) is soaring. Covid-19 will promote the demand growth of Deoxynucleotide Triphosphates (dNTPs) industry.

    Region Overview:
    In 2022, the share of the Deoxynucleotide Triphosphates (dNTPs) market in North America stood at 36.51%.

    Company Overview:
    Thermo Scientific is one of the major players operating in the Deoxynucleotide Triphosphates (dNTPs) market, holding a share of 22.31% in 2023.

    Thermo Scientific
    Thermo Fisher Scientific is an American supplier of scientific instrumentation, reagents and consumables, and software and services to healthcare, life science, and other laboratories in academia, government, and industry (including in the biotechnology and pharmaceutical sectors). Based in Waltham, Massachusetts, Thermo Fisher was created in 2006 by the merger of Thermo Electron and Fisher Scientific.

    Merck Millipore
    Merck Millipore was the brand used by Merck Group's (not US-based Merck & Co.) global life science business until 2015 when the company re-branded. It was formed when Merck acquired the Millipore Corporation in 2010. Merck is a supplier to the life science industry.

    Segmentation Overview:
    By type, Liquid segment accounted for the largest share of market in 2022.

    Application Overview:
    By application, the Pharmaceutical segment occupied the biggest share from 2018 to 2022.

    The Deoxynucleotide Triphosphates (dNTPs) market report covers sufficient and comprehensive data on market introduction, segmentations, status and trends, opportunities and challenges, industry chain, competitive analysis, company profiles, and trade statistics, etc. It provides in-depth and all-scale analysis of each segment of types, applications, players, 5 major regions and sub-division of major countries, and sometimes end user, channel, technology, as well as other information individually tailored before order confirmation.

    Meticulous research and analysis were conducted during the preparation process of the report. The qualitative and quantitative data were gained and verified through primary and secondary sources, which include but not limited to Magazines, Press Releases, Paid Databases, Maia Data Center, National Customs, Annual Reports, Public Databases, Expert interviews, etc. Besides, primary sources include extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs, and marketing executives, downstream distributors, as well as end-clients.

    In this report, the historical period starts from 2018 to 2022, and the forecast period ranges from 2023 to 2028. The facts and data are demonstrated by tables, graphs, pie charts, and other pictorial representations, which enhances the effective visual representation and decision-making capabilities for business strategy.

    Key Companies in the global Deoxynucleotide Triphosphates (dNTPs) market covered in Chapter 4:
    Promega
    Jena Bioscience
    Cytiva
    Merck Millipore
    NEB
    Meridian Bioscience
    Geneaid
    Takara Bio
    Qiagen
    Thermo Scientific

    In Chapter 12 and Chapter 14.1, on the basis of types, the Deoxynucleotide Triphosphates (dNTPs) market from 2018 to 2028 is primarily split into:
    Liquid
    Solid

    In Chapter 13 and Chapter 14.2, on the basis of the Downstream Industry, the Deoxynucleotide Triphosphates (dNTPs) market from 2018 to 2028 covers:
    Pharmaceutical
    Research Institutions

    Geographically, the detailed analysis of consumption, revenue, market share and growth rate, history and forecast (2018-2028) of the following regions are covered in Chapters 6, 7, 8, 9, 10, 11, 15:
    North America (United States, Canada, Mexico)
    Europe (Germany, United Kingdom, France, Italy, Spain)
    Asia Pacific (China, Japan, South Korea, India, Southeast Asia)
    South America (Brazil, Argentina)
    Middle East & Africa (Saudi Arabia, UAE, South Africa)

    Outline:
    Chapter 1 begins with the Deoxynucleotide Triphosphates (dNTPs) market scope and definition, product segment introduction, global overall market size, as well as market dynamics scenarios such as opportunities, challenges, and industry development trends under inflation. It offers a high-level view of the current state of the Deoxynucleotide Triphosphates (dNTPs) market and its likely evolution in the short to mid-term and long term.

    Chapter 2 provides Deoxynucleotide Triphosphates (dNTPs) industry chain analysis, covering raw materials analysis, cost structure, price estimate, and forecast, along with price-impacting factors, downstream channels, and major customers. It aims to help readers to grab insights into product upstream, midstream, and downstream fields.

    Chapter 3 depicts Deoxynucleotide Triphosphates (dNTPs) industry competitive analysis regarding market concentration rate, saturation rate, feasibility analysis from new entrants, as well as substitute's status and trends. It indicates the developing space and prospects of the current industry.

    Chapter 4 analyzes extensive company profiles, comprising company basic info, product or service profiles, and sales, price, value, gross, and gross margin 2018-2023. It incorporates the Deoxynucleotide Triphosphates (dNTPs) market ranking, benchmarks, and company business portfolio.

    Chapter 5 presents trade statistics of import and export volume from 2018-2023, demonstrating domestic and international market comparisons in specific countries.

    Chapters 6-10 highlight Deoxynucleotide Triphosphates (dNTPs) market status at the regional and country levels, including 5 major regions of North America, Europe, Asia Pacific, the Middle East and Africa, and Latin America. The region and country list in the sample is only for reference, and it can be adjusted as required.

    Chapter 11 involves geographical market figures of sales, value, market share, and growth rate. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of each specific region.

    Chapters 12-13 evaluate the Deoxynucleotide Triphosphates (dNTPs) market based on different types and applications. It focuses on sales and value of 2018-2023 from both vertical and horizontal perspectives.

    Chapters 14-15 elaborate on the Deoxynucleotide Triphosphates (dNTPs) market forecast data from 2023-2028, segmented by types and applications, regions, and major countries, helping readers to know future aspects and growth trends.

    Chapter 16 ends with an elaboration of data sources and research methodology. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

    Years considered for this report:


    Historical Years:

    2018-2022

    Base Year:

    2022

    Estimated Year:

    2023

    Forecast Period:

    2023-2028

    Frequently Asked Questions



    This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.

    • By product type
    • By End User/Applications
    • By Technology
    • By Region

    The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
    market Reports market Reports